Diabetic nephropathy is currently the single largest cause of endstage
renal disease (ESRD) in the United States and many European countries
. The primary cause for the development of diabetic complications (inc
luding diabetic nephropathy) is persistent exposure to hyperglycemia,
although genetic and other incompletely understood factors also play a
n important role. Although much consideration has been given to the pa
thogenesis and genetics of the disease itself, the mechanisms by which
persistent exposure to hyperglycemia cause biochemical and metabolic
alterations have been very sketchily understood. Recently, a growing b
ody of evidence has linked the accumulation of the late products of gl
ucose-protein interaction to a variety of chronic complications, inclu
ding diabetic nephropathy. The formation of irreversible advanced glyc
osylation endproducts (AGEs) resulting from the spontaneous reaction b
etween glucose and proteins occur most noticeably on long-lived struct
ural proteins. Recent studies demonstrate that the pathogenesis of dia
betic nephropathy is caused by the hyperglycemia-accelerated formation
of AGEs. Also, reactive AGE peptides in the circulation are thought t
o play a role as a new version of so called middle molecule toxic subs
tances. This evidence is opening a new window for our understanding of
the pathogenesis of diabetic nephropathy.